Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 8/20 | 0.66 |
| ▸ | TACR1 | P25103 | 2/20 | 0.60 |
| ▸ | CTSB | P07858 | 3/20 | 0.59 |
| ▸ | CTSS | P25774 | 1/20 | 0.59 |
| ▸ | CTSK | P43235 | 1/20 | 0.59 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27649629 | 1.00 | CTSL (0.66) | CTSLTACR1CTSBCTSSCTSK | |
| SCHEMBL8668091 | 0.89 | TACR1 (0.70) | CTSLTACR1CTSBCTSSCTSK | |
| SCHEMBL30902878 | 0.88 | MME (0.56) | CTSLTACR1CTSBCTSSCTSK | |
| SCHEMBL6383945 | 0.87 | CTSK (0.66) | CTSLCTSBCTSSCTSKSIRT5 | |
| SCHEMBL27649586 | 0.87 | CTSK (0.55) | CTSLCTSBCTSSCTSKSIRT5 | |
| SCHEMBL6384766 | 0.87 | CTSK (0.55) | CTSLCTSBCTSSCTSKSIRT5 | |
| SCHEMBL10397579 | 0.87 | MME (0.67) | CTSLTACR1CTSBCTSSCTSK | |
| SCHEMBL31243057 | 0.85 | CTSL (0.57) | CTSLCTSSCTSKSIRT5 | |
| SCHEMBL31243031 | 0.85 | SIRT2 (0.62) | CTSLCTSSCTSKSIRT5 | |
| SCHEMBL6278137 | 0.85 | FOLH1 (0.67) | CTSLCTSSSIRT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1492523-A2 | METHOD FOR IDENTIFICATION OF TUMOR TARGETING ENZYMES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2005-01-05 | — | — | EP | disclosed |
| US-20030138864-A1 | Method for identifying an enzyme to design anti-cancer compounds | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-07-24 | — | — | US | disclosed |
| WO-2003043631-A2 | METHOD FOR IDENTIFICATION OF TUMOR TARGETING ENZYMES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030138864-A1 | Method for identifying an enzyme to design anti-cancer compounds | RNASE1, GUSB, DPEP1 | CTSL 526/4885TACR1 2323/4885CTSB 316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.